Fundamental dimension Equity attribute | CAASLeader $4.33▼-0.92% Cap $130.6MP/E 2.3x QuantScore53/100 | AKAPeer $10.55▲+3.94% Cap $116.0MP/E -4.2x QuantScore35/100 | CJETPeer $1.71▲+6.21% Cap $555.5KP/E -0.0x QuantScore22/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
55/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 80/100 | 37/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 61/100 | 10/100 | 23/100 |
Growth Revenue / earnings growth & margins | 46/100 | 23/100 | 17/100 |
Sentiment Analyst ratings, targets & revisions | — | 50/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 2.3x | -4.2x | -0.0x |
Forward P/E (next FY) | — | -6.2x | — |
EV / EBITDA (TTM) | 1.2x | 95.3x | -12.3x |
Price / Sales | 0.2x | 0.2x | 0.1x |
Price / Free Cash Flow | 1.6x | 12.8x | -0.0x |
PEG ratio | 0.02 | 1.05 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 4 / 9 | 3 / 9 |
Altman Z-Score | 1.92 (Grey) | 0.47 (Distress) | -2.82 (Distress) |
Total debt / equity | 0.17 | 2.26 | -2.03 |
Quick ratio | 1.2x | 0.4x | 0.1x |
Interest coverage | 49.5x | -1.6x | -3.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +17.6% | +4.4% | -27.1% |
Net income growth YoY | +42.9% | -20.9% | +31.1% |
Gross margin (TTM) | 20.9% | 59.6% | -359.0% |
Operating margin (FY) | 7.8% | -1.1% | -828.3% |
FCF margin (FY) | 9.3% | -0.1% | -384.0% |
5. Trailing price performancePrice change over period |
1M return | -14.8% | -3.5% | 0.0% |
3M return | -0.5% | -3.8% | -69.2% |
6M return | -3.1% | -5.4% | -85.4% |
Year to date | +1.6% | -1.4% | +359.2% |
1Y return | -1.6% | -27.2% | -99.1% |
3Y return | +32.0% | +55.6% | -100.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-1.38 -131.8% premium | $-119.31 -1230.9% premium | $-5,468.36 -319887.2% premium |
Wall Street consensus target | — — | $17.50 +65.9% · range $10.00–$25.00 | — — |
Consensus stance | — | 18% Buy82% Hold-0% Sell | — |